- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aeolus Pharmaceuticl (AOLS)
Aeolus Pharmaceuticl stock price live, this page displays OTC AOLS stock exchange data. View the AOLS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Aeolus Pharmaceuticl real time stock price chart below.
What Is the Aeolus Pharmaceuticl Stock Price Today?
The Aeolus Pharmaceuticl stock price today is 0.0001.
What Is the Stock Symbol for Aeolus Pharmaceuticl?
The stock symbol for Aeolus Pharmaceuticl is ""AOLS.""
What Stock Exchange Does Aeolus Pharmaceuticl Trade On?
Aeolus Pharmaceuticl is listed and trades on the OTC Markets stock exchange.
Is Aeolus Pharmaceuticl a Good Stock to Buy?
Determining whether Aeolus Pharmaceuticl—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AOLS quote. (ISIN: US00765G1094)
What Is the Aeolus Pharmaceuticl Stock Price Today?
The Aeolus Pharmaceuticl stock price today is 0.0001.
What Is the Stock Symbol for Aeolus Pharmaceuticl?
The stock symbol for Aeolus Pharmaceuticl is ""AOLS.""
What Stock Exchange Does Aeolus Pharmaceuticl Trade On?
Aeolus Pharmaceuticl is listed and trades on the OTC Markets stock exchange.
Is Aeolus Pharmaceuticl a Good Stock to Buy?
Determining whether Aeolus Pharmaceuticl—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AOLS quote. (ISIN: US00765G1094)
OTC Markets
Currency in USD
0.0001
0.0000(0.00%)
Delayed Data·
Fair Value
An estimate of a Aeolus Pharmaceuticl's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0001
0.0001
52 wk Range
0.0001
0.0050
AOLS Scorecard
Full Analysis
Stock generally trades with low price volatility
Trading near 52-week Low
1/2
Fair Value
An estimate of a Aeolus Pharmaceuticl's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.00010.0001
52 wk Range
0.00010.0050
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
AOLS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Aeolus Pharmaceuticl's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell
Aeolus Pharmaceuticl Company Profile
Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and oncology. Its lead compound includes AEOL 10150 that has completed two Phase I clinical trials, which is developed against the pulmonary sub-syndrome of acute radiation syndrome; and for use as a medical countermeasure for exposure to chemical vesicants and nerve agents. The company is also developing AEOL 11114B, AEOL 11203, and AEOL 11207 for the treatment of Parkinson’s disease, as well as AEOL 20415 for treating infectious diseases. Aeolus Pharmaceuticals, Inc. was founded in 1994 and is based in Mission Viejo, California.
Compare AOLS to Peers and Sector
Metrics to compare | AOLS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAOLSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −0.3x | −0.5x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.0x | 0.9x | 2.6x | |
Price / LTM Sales | 0.0x | 1.8x | 3.3x | |
Upside (Analyst Target) | 0.0% | 157.6% | 38.7% | |
Fair Value Upside | Unlock | 14.3% | 5.0% | Unlock |
Earnings
Latest Release
Feb 17, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
13.00K / --
FAQ
What Stock Exchange Does Aeolus Pharmaceuticl Trade On?
Aeolus Pharmaceuticl is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Aeolus Pharmaceuticl?
The stock symbol for Aeolus Pharmaceuticl is "AOLS."
What Is the Aeolus Pharmaceuticl Market Cap?
As of today, Aeolus Pharmaceuticl market cap is 15.21K.
What Is Aeolus Pharmaceuticl's Earnings Per Share (TTM)?
The Aeolus Pharmaceuticl EPS (TTM) is -0.03.
From a Technical Analysis Perspective, Is AOLS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Aeolus Pharmaceuticl Stock Split?
Aeolus Pharmaceuticl has split 1 times.
How Many Employees Does Aeolus Pharmaceuticl Have?
Aeolus Pharmaceuticl has 4 employees.
What is the current trading status of Aeolus Pharmaceuticl (AOLS)?
As of 27 Aug 2025, Aeolus Pharmaceuticl (AOLS) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.01.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.